CV Therapeutics Prices $131 Million Public Equity Offering
-Dec 4, 2001 07:00 AM (PR Newswire)
-http://finance.lycos.com/home/news/story.asp?story=25595793
===========================================================================
/FROM PR NEWSWIRE SAN FRANCISCO 415-543-7800/
[STK] CVTX
[IN] BIO
[SU] OFR
TO BUSINESS AND MEDICAL EDITORS:
CV Therapeutics Prices $131 Million Public Equity Offering
PALO ALTO, Calif., Dec. 4 /PRNewswire/ --
CV Therapeutics, Inc. (NASDAQ:CVTX) today announced that it has priced a
public offering of 2.5 million shares of its common stock at a purchase price
of $52.50 per share. All of the shares were offered by CV Therapeutics, Inc.
In addition, the Company has granted the underwriters an option to purchase an
additional 375,000 shares of common stock to cover over-allotments if any.
J.P. Morgan Securities Inc. and Robertson Stephens, Inc. are acting as
joint lead managers of the offering, with J.P. Morgan Securities Inc. as the
sole bookrunner. Bear, Stearns & Co. Inc., CIBC World Markets Corp., Morgan
Stanley & Co. Incorporated, SG Cowen Securities Corporation, U.S. Bancorp
Piper Jaffray Inc., and First Albany Corporation are acting as co-managers.
The offering is expected to close on December 7, 2001. Information about this
offering is available in the prospectus filed with the Securities and Exchange
Commission. |
